4//SEC Filing
CUMBERLAND PHARMACEUTICALS INC 4
Accession 0001209191-15-029972
$CPIXCIK 0001087294operating
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 5:26 PM ET
Size
4.6 KB
Accession
0001209191-15-029972
Insider Transaction Report
Form 4
Greene Rick Scott
Chief Financial Officer
Transactions
- Award
Common Stock
2015-03-27$6.86/sh+3,000$20,580→ 45,000 total
Footnotes (1)
- [F1]Restricted stock award will vest 100% on March 17, 2019.
Documents
Issuer
CUMBERLAND PHARMACEUTICALS INC
CIK 0001087294
Entity typeoperating
IncorporatedTN
Related Parties
1- filerCIK 0001087294
Filing Metadata
- Form type
- 4
- Filed
- Mar 26, 8:00 PM ET
- Accepted
- Mar 27, 5:26 PM ET
- Size
- 4.6 KB